A novel echocardiographic risk score for light-chain amyloidosis

AIMS: The prognosis of light-chain (AL) amyloidosis, a plasma cell dyscrasia, is largely determined by the presence of cardiac involvement. Conventional staging is achieved using cardiac biomarkers (high-sensitivity troponin, N-terminal pro-beta natriuretic peptide) and free light-chain difference (...

Descripción completa

Detalles Bibliográficos
Autores principales: Geenty, Paul, Sivapathan, Shanthosh, Stefani, Luke D, Zada, Matthew, Boyd, Anita, Richards, David, Kwok, Fiona, Thomas, Liza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152390/
https://www.ncbi.nlm.nih.gov/pubmed/37143609
http://dx.doi.org/10.1093/ehjopen/oead040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152390/
https://www.ncbi.nlm.nih.gov/pubmed/37143609
http://dx.doi.org/10.1093/ehjopen/oead040

Ejemplares similares